{"id":"NCT03589885","sponsor":"Novartis Pharmaceuticals","briefTitle":"Study of Efficacy and Safety of Secukinumab 2 mL Auto-injector (300 mg) in Subjects With Moderate to Severe Plaque Psoriasis","officialTitle":"Multicenter, rAndomized, Double-blind, Placebo-conTrolled, 52-week stUdy to demonstRatE the Efficacy, Safety and Tolerability of Secukinumab Injections With 2 mL Auto-injectors (300 mg) in Adult Subjects With Plaque Psoriasis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-12-19","primaryCompletion":"2019-11-19","completion":"2020-08-05","firstPosted":"2018-07-18","resultsPosted":"2021-08-26","lastUpdate":"2021-10-11"},"enrollment":122,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Plaque Psoriasis"],"interventions":[{"type":"DRUG","name":"Placebo 2 mL auto-injector","otherNames":["Placebo"]},{"type":"DRUG","name":"Placebo 1 mL prefilled syringe","otherNames":["Placebo"]},{"type":"DRUG","name":"Secukinumab 2 mL auto-injector","otherNames":[]},{"type":"DRUG","name":"Secukinumab 1 mL prefilled syringe","otherNames":[]}],"arms":[{"label":"Placebo 2 mL auto-injector","type":"PLACEBO_COMPARATOR"},{"label":"Placebo 1 mL prefilled syringe","type":"PLACEBO_COMPARATOR"},{"label":"Secukinumab 2 mL auto-injector","type":"EXPERIMENTAL"},{"label":"Secukinumab 1 mL prefilled syringe","type":"ACTIVE_COMPARATOR"}],"summary":"The primary purpose of this study is to assess efficacy, safety and tolerability of a 2 mL pre-filled auto-injector (AI) of 300 mg secukinumab in patients with moderate to severe plaque psoriasis","primaryOutcome":{"measure":"PASI 75 Response After 12 Weeks of Treatment","timeFrame":"12 weeks","effectByArm":[{"arm":"Secukinumab 2 mL Auto-injector","deltaMin":39,"sd":null},{"arm":"Secukinumab 1 mL Prefilled Syringe","deltaMin":34,"sd":null},{"arm":"Placebo","deltaMin":4,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":22,"countries":["United States","Canada","Germany","Iceland","Poland","Spain"]},"refs":{"pmids":[],"seeAlso":["https://www.novctrd.com/ctrdweb/patientsummary/patientsummaries?patientSummaryId=815"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":41},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Influenza like illness","Headache","Hypertension"]}}